A Multicenter Multinational Observational Study of Children With Hypochondroplasia

Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia

NCT06455059 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.

NCT03794609 ·Status: TERMINATED

A Multi-center, Longitudinal, Observational Study of Children With Achondroplasia

NCT03875534 ·Status: COMPLETED

A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)

NCT02724228 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study in Children With Achondroplasia

NCT07301463 ·Status: RECRUITING

Achondroplasia Natural History Multicenter Clinical Study

NCT02597881 ·Status: RECRUITING

A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia

NCT02055157 ·Status: COMPLETED ·Phase: PHASE2

An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

NCT03424018 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Skeletal Disorders and Short Stature

NCT00001754 ·Status: COMPLETED

Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)

NCT04035811 ·Status: COMPLETED

Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)

NCT05328050 ·Status: RECRUITING

A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia

NCT05353192 ·Status: UNKNOWN ·Phase: PHASE4

Molecular Basis of the Growth Axis in Short Stature

NCT00453245 ·Status: COMPLETED

Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

NCT00174187 ·Status: TERMINATED ·Phase: PHASE3

An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia

NCT03989947 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia

NCT03583697 ·Status: COMPLETED ·Phase: PHASE2

Growth Retardation In Children With Special Pathological Conditions Or Disease

NCT00163215 ·Status: COMPLETED ·Phase: PHASE3

Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

NCT00163189 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

NCT03197766 ·Status: COMPLETED ·Phase: PHASE3

Testing the Feasibility of a Novel Growth Monitoring Smartphone App

NCT05829252 ·Status: COMPLETED

Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

NCT00174291 ·Status: TERMINATED ·Phase: PHASE3

Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)

NCT01052623 ·Status: UNKNOWN ·Phase: PHASE4

A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome

NCT00017927 ·Status: COMPLETED ·Phase: PHASE3

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

NCT00001595 ·Status: RECRUITING

The Treatment and Natural History of Acromegaly

NCT00001981 ·Status: COMPLETED